5:08 PM ET
10-Q
Financial Results
Kairos Pharma Q3 2026 Results: Net Loss of $1.98M, Loss Widens
Kairos Pharma, Ltd. reported a net loss of $5.03 million for the nine months ended September 30, 2026, compared to a $4.08 million loss in the prior year period. The company remains in the development stage with no revenue, and its cash position decreased to $3.13 million as of September 30, 2026, from $4.49 million at year-end 2025.
- Key figure
- Net loss $1.98M